Results 181 to 190 of about 491,703 (337)

Impact on survival of 12 versus 3 monthly cycles of paclitaxel (175 mg/m2) administered to patients with advanced ovarian cancer who attained a complete response to primary platinum-paclitaxel: Follow-up of a Southwest Oncology Group and Gynecologic Oncology Group phase 3 trial [PDF]

, 2009
Maurie Markman, Pan Liu, James Moon, Bradley J. Monk, Larry J. Copeland, Sharon P. Wilczynski, David S. Alberts   +6 more
openalex   +1 more source

Surgical site infections and sepsis in gynecological surgery

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Despite advancements in infection control, surgical site infections (SSIs) and postoperative sepsis remain significant challenges in gynecological surgery, contributing to increased morbidity, mortality, and healthcare costs. In low‐income countries, circulatory failure due to septic shock leads to most deaths after surgery, with sepsis ...
Cristina Taliento, Gennaro Scutiero, Carmelia Milano, Mattia Grasso, Francesca Nitti, Orsola Brasile, Ruby Martinello, Giulia Bernardi, Stefano Restaino, Martina Arcieri, Matteo Pavone, Nicolò Bizzarri, Giuseppe Vizzielli, Pantaleo Greco   +13 more
wiley   +1 more source

Cervical Cancer Outcomes in Mozambique: Impact of an International Gynecologic Oncology Training Program. [PDF]

JCO Glob Oncol
Rangeiro R, Lopes A, Munsell MF, Changule D, Daud S, Ferreira C, Ribeiro M, Mabota F, Luis E, Daniel A, Tsambe E, Bila C, Fontes-Cintra G, Moretti-Marques R, Vieira M, Alvarenga-Bezerra V, Carrilho C, Baker E, Lorenzoni C, Schmeler KM, Salcedo MP.   +20 more
europepmc   +1 more source

Oncologic outcome and recurrence patterns of clinical stage IB and IIA cervical cancer: A large retrospective analysis of a tertiary reference center

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To evaluate the outcomes and recurrence patterns and define the parameters that can help to predict high‐risk patients among our 20‐year clinical early‐stage IB–IIA cervical cancer patients treated with traditional (non‐nerve sparing) radical surgery.
Osman Aşıcıoğlu, Sinan Ateş, Füsun Varol, Tülin Deniz Yalta, Cenk Sayın   +4 more
wiley   +1 more source

Integration of a lifestyle modification intervention for women with overweight and obesity in a gynecologic oncology practice. [PDF]

Gynecol Oncol
Morris DH, Kosmacki A, Tolby L, Marx C, Vanderlan J, Mutch DG, Colditz G, Hagemann AR.   +7 more
europepmc   +1 more source

Topotecan Weekly Versus Conventional 5-Day Schedule in Patients With Platinum-Resistant Ovarian Cancer: A Randomized Multicenter Phase II Trial of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group [PDF]

, 2010
Jalid Sehouli, Dirk Stengel, Philipp Harter, Christian Kurzeder, Antje Belau, Thomas Bogenrieder, Susanne Markmann, Sven� Mahner, Lothar Mueller, Ralf Lorenz, A. Nugent, Jochen Wilke, Andreas Kuznik, Gabriele Doering, A. Wischnik, Harald Sommer, H.G. Meerpohl, W. Schroeder, W. Lichtenegger, Guelten Oskay-Oezcelik   +19 more
openalex   +1 more source

Obstetric characteristics and maternal outcomes of early second‐trimester placenta accreta spectrum

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To describe early second‐trimester placenta accreta spectrum (PAS) management and outcomes. Methods This cross‐sectional study queried the US Healthcare Cost and Utilization Project's National Inpatient Sample from 2016 to 2021, finding 905 cases with a diagnosis of PAS between 14 and 22 weeks of gestation and in‐hospital management.
Mihiri S. Karunaratne, Shinya Matsuzaki, Kazuhide Matsushima, Jane L. Yang, Rachel S. Mandelbaum, Laila I. Muderspach, Joseph G. Ouzounian, Koji Matsuo, Brian T. Nguyen   +8 more
wiley   +1 more source

Translational research in the Gynecologic Oncology Group: Evaluation of ovarian cancer markers, profiles, and novel therapies [PDF]

, 2010
Kathleen M. Darcy, Michael J. Birrer
openalex   +1 more source

Cancer of the vulva: 2025 update

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Vulvar cancer is an uncommon gynecological malignancy primarily affecting postmenopausal women. No specific screening exists and the most effective strategy to reduce the incidence of vulvar cancer is the opportune treatment of predisposing and preneoplastic lesions associated with its development.
Alexander B. Olawaiye, Mauricio A. Cuello, Sushil Beriwal, Linda J. Rogers   +3 more
wiley   +1 more source

AI-driven simplification of surgical reports in gynecologic oncology: A potential tool for patient education. [PDF]

Acta Obstet Gynecol Scand
Riedel M, Meyer B, Kfuri Rubens R, Riedel C, Amann N, Kiechle M, Riedel F.   +6 more
europepmc   +1 more source